News
Over the last 2 years, Vivifi Biotech has made progress towards a trial that aims to overcome the challenges of the last trial. Now, it's starting work on the final phase of planning.
An update on who we met at the Labour and Conservative party conferences
A study following Scottish international rugby players shows they are more likely to develop neurodegenerative conditions compared to the general public.
Jeremy Paxman has opened up about his experience of living with Parkinson's.
A project involving Parkinson's UK, shows promise for using artificial intelligence to identify Parkinson's in brains donated to our Brain Bank.
Results from a US study show that a hormone called irisin has the potential to halt the progression of Parkinson's in mice.
Scientists at the University of Manchester have developed a test which could help diagnose Parkinson's in 3 minutes using a simple skin swab.
The £2.9m phase 2 trial of a drug that could slow the progression of conditions like Parkinson's will be funded by the Parkinson's Virtual Biotech, our international drug discovery and development programme.
The grants will help activity providers deliver classes designed specifically for people with Parkinson's.